[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6956 Introduced in House (IH)]
<DOC>
118th CONGRESS
2d Session
H. R. 6956
To amend title XIX of the Social Security Act to prohibit the Secretary
of Health and Human Services from treating any Medicaid-related funds
recovered from one or more pharmaceutical companies or drug
distributors with respect to opioid litigation as an overpayment under
such title, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 11, 2024
Ms. Kaptur (for herself and Mrs. Hinson) introduced the following bill;
which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend title XIX of the Social Security Act to prohibit the Secretary
of Health and Human Services from treating any Medicaid-related funds
recovered from one or more pharmaceutical companies or drug
distributors with respect to opioid litigation as an overpayment under
such title, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Opioid Settlement Accountability
Act''.
SEC. 2. PROHIBITION ON TREATING ANY MEDICAID-RELATED FUNDS RECOVERED
FROM ONE OR MORE PHARMACEUTICAL COMPANIES OR DRUG
DISTRIBUTORS WITH RESPECT TO OPIOID LITIGATION AS AN
OVERPAYMENT.
(a) In General.--Section 1903(d)(3) of the Social Security Act (42
U.S.C. 1396(d)(3)) is amended by adding at the end the following new
subparagraph:
``(C)(i) Subparagraph (A) and paragraph (2)(B) may not apply to any
amount recovered or paid to a State on or after December 31, 2025, as a
part of a comprehensive settlement of opioid litigation between
pharmaceutical manufacturers (as defined in the second sentence of
section 102(15) of the Controlled Substances Act) or drug distributors
(as defined in the second sentence of section 102(12) of such Act) and
State attorneys general, or as a part of any individual State
settlement or judgement reached in such litigation initiated or pursued
by a State against one or more such companies or distributors.
``(ii) A State shall use amounts recovered or paid to the State as
a part of comprehensive or individual settlement, or a judgement,
described in clause (i) for--
``(I) supporting access to treatment (including medication
assisted treatment) and health care services (including
services provided by federally certified opioid treatment
programs or other appropriate health care providers to treat
individuals with opioid use disorder and subsequent support and
wrap around services that encourage employment and
reintegration to society);
``(II) education related to opioid use disorder;
``(III) implementing prevention activities, including the
reduction of the furnishing of opioids by health care
practitioners and introduction of non-opioid pain management
approaches;
``(IV) training for health care practitioners with respect
to best practices for prescribing opioids, pain management,
educating patients of the risk of opioid use to treat chronic
and acute conditions, recognizing potential cases of substance
abuse, referral of patients to treatment programs, and overdose
prevention;
``(V) supporting State and Federal law enforcement actions
and first responder capital equipment relating to the illegal
distribution of opioids and opioid analogues; and
``(VI) any other public health-related activities and
social support services (including housing, employment, child-
well being, criminal justice, and emergency management)
relating to addressing the opioid abuse crisis within such
State, as such State determines appropriate; and
evaluating at least one of the activities described in this clause to
identify effective strategies to prevent opioid abuse and substance
abuse disorders.''.
(b) Retroactive Effective Date.--The amendment made by this section
shall take effect as if enacted on January 1, 2019.
<all>